FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

24416611000001109: Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Apr 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
79165901000001119 Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
79166001000001111 Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Is a Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials 10 vial true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has AMP Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has specific active ingredient Cilastatin sodium false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has specific active ingredient Imipenem monohydrate false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Imipenem true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cilastatin true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has specific active ingredient Imipenem monohydrate true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has basis of strength substance Imipenem true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has basis of strength substance Cilastatin true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has specific active ingredient Cilastatin sodium true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start